ESC 2020: Amarin details positive Vascepa data amid looming threat for US market generic entry

GlobalData believes that Amarin has the opportunity to leverage the newly presented results to reinforce physician education and reach its blockbuster opportunity in this region. Credit: Matej Kastelic / Shutterstock.



  • Vascepa